- Home
- BBOT vs QD Comparison
BBOT vs QD Comparison
Compare BBOT & QD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBOT
- QD
- Stock Information
- Founded
- BBOT 2016
- QD 2014
- Country
- BBOT United States
- QD China
- Employees
- BBOT N/A
- QD N/A
- Industry
- BBOT Biotechnology: Pharmaceutical Preparations
- QD Finance: Consumer Services
- Sector
- BBOT Health Care
- QD Finance
- Exchange
- BBOT Nasdaq
- QD Nasdaq
- Market Cap
- BBOT 902.8M
- QD 761.2M
- IPO Year
- BBOT N/A
- QD 2017
- Fundamental
- Price
- BBOT $10.93
- QD $4.46
- Analyst Decision
- BBOT Strong Buy
- QD
- Analyst Count
- BBOT 4
- QD 0
- Target Price
- BBOT $25.00
- QD N/A
- AVG Volume (30 Days)
- BBOT 211.1K
- QD 334.4K
- Earning Date
- BBOT 11-26-2025
- QD 11-21-2025
- Dividend Yield
- BBOT N/A
- QD N/A
- EPS Growth
- BBOT N/A
- QD N/A
- EPS
- BBOT N/A
- QD 0.42
- Revenue
- BBOT N/A
- QD $19,058,373.00
- Revenue This Year
- BBOT N/A
- QD N/A
- Revenue Next Year
- BBOT N/A
- QD N/A
- P/E Ratio
- BBOT N/A
- QD $10.52
- Revenue Growth
- BBOT N/A
- QD N/A
- 52 Week Low
- BBOT $8.70
- QD $2.04
- 52 Week High
- BBOT $13.18
- QD $5.08
- Technical
- Relative Strength Index (RSI)
- BBOT N/A
- QD 52.43
- Support Level
- BBOT N/A
- QD $4.29
- Resistance Level
- BBOT N/A
- QD $4.51
- Average True Range (ATR)
- BBOT 0.00
- QD 0.19
- MACD
- BBOT 0.00
- QD -0.01
- Stochastic Oscillator
- BBOT 0.00
- QD 44.23
About BBOT BridgeBio Oncology Therapeutics Inc. Common Stock
BridgeBio Oncology Therapeutics Inc, formerly BridgeBio Oncology Therapeutics is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes.
About QD Qudian Inc. each representing one
Qudian Inc is a consumer-oriented technology company engaged in the operation of online platforms to provide small consumer credit products in the People's Republic of China. It aims to empower financial institutions with its technological capabilities, help them improve marketing and operating efficiency, and enable financial institutions to efficiently connect their diversified financial products with scene traffic across the entire network It derives a majority of its revenue from the People's Republic of China.